Witnessing the stock’s movement on the chart, on Wednesday, Agios Pharmaceuticals Inc (NASDAQ: AGIO) set off with pace as it heaved 3.90% to $28.54, before settling in for the price of $27.47 at the close. Taking a more long-term approach, AGIO posted a 52-week range of $22.24-$46.00.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -160.74%. This publicly-traded company’s shares outstanding now amounts to $58.28 million, simultaneously with a float of $54.95 million. The organization now has a market capitalization sitting at $1.66 billion. At the time of writing, stock’s 50-day Moving Average stood at $32.17, while the 200-day Moving Average is $34.13.
Agios Pharmaceuticals Inc (AGIO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Agios Pharmaceuticals Inc’s current insider ownership accounts for 5.77%, in contrast to 101.97% institutional ownership. According to the most recent insider trade that took place on Jan 05 ’26, this organization’s Chief Commercial Officer sold 2,872 shares at the rate of 27.02, making the entire transaction reach 77,601 in total value, affecting insider ownership by 34,793.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Let’s observe the current performance indicators for Agios Pharmaceuticals Inc (AGIO). It’s Quick Ratio in the last reported quarter now stands at 13.39. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 37.16.
In the same vein, AGIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.96, a figure that is expected to reach -1.96 in the next quarter, and analysts are predicting that it will be -6.49 at the market close of one year from today.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Going through the that latest performance of [Agios Pharmaceuticals Inc, AGIO]. Its last 5-days volume of 1.02 million was inferior to the volume of 1.06 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 55.74% While, its Average True Range was 59.25.
Raw Stochastic average of Agios Pharmaceuticals Inc (AGIO) in the period of the previous 100 days is set at 26.52%, which indicates a major fall in contrast to 74.49% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.18 that was lower than 1.54 volatility it exhibited in the past 100-days period.
